The inhibition of inflammasome by Brazilian propolis (EPP-AF)

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Hori, Juliana I ^a   Zamboni, Dario S ^a   Carrão, Daniel B ^b   Goldman, Gustavo Henrique ^a,c   Berretta, Andresa A ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Apis Flora Industrial e Comercial LTDA   (Brazil)

^c BRAZILIAN CENTER FOR RESEARCH IN ENERGY AND MATERIALS CNPEM   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AROMADENDRIN; ARTEPILLIN C; CAFFEIC ACID; CINNAMIC ACID; COUMARIC ACID; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PROPOLIS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMICAL COMPOSITION; CYTOKINE RELEASE; ENZYME ACTIVATION; LEGIONELLA PNEUMOPHILA; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 84877277964     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/418508     Document Type: Article

References (72)

1. Burdock G. A., Review of the biological properties and toxicity of bee propolis (propolis). Food and Chemical Toxicology 1998 36 4 347 363 2-s2.0-0032489791 10.1016/S0278-6915(97)00145-2 (Pubitemid 28255348)
2. Banskota A. H., Tezuka Y., Kadota S., Recent progress in pharmacological research of propolis. Phytotherapy Research 2001 15 7 561 571 2-s2.0-0034753678 10.1002/ptr.1029 (Pubitemid 33021859)
3. Sforcin J. M., Fernandes A. Jr., Lopes C. A. M., Bankova V., Funari S. R. C., Seasonal effect on Brazilian propolis antibacterial activity. Journal of Ethnopharmacology 2000 73 1-2 243 249 2-s2.0-0033806545 10.1016/S0378-8741(00) 00320-2
4. de Barros M. P., Sousa J. P. B., Bastos J. K., de Andrade S. F., Effect of Brazilian green propolis on experimental gastric ulcers in rats. Journal of Ethnopharmacology 2007 110 3 567 571 2-s2.0-33847703665 10.1016/j.jep.2006.10. 022 (Pubitemid 46386368)
5. Barros M. P. D., Lemos M., Maistro E. L., Leite M. F., Sousa J. P. B., Bastos J. K., Andrade S. F. D., Evaluation of antiulcer activity of the main phenolic acids found in Brazilian green propolis. Journal of Ethnopharmacology 2008 120 3 372 377 2-s2.0-56349123761 10.1016/j.jep.2008.09.015 (Pubitemid 50318830)
6. Paulino N., Abreu S. R. L., Uto Y., Koyama D., Nagasawa H., Hori H., Dirsch V. M., Vollmar A. M., Scremin A., Bretz W. A., Anti-inflammatory effects of a bioavailable compound, artepillin C, in Brazilian propolis. European Journal of Pharmacology 2008 587 1-3 296 301 2-s2.0-44149099992 10.1016/j.ejphar.2008.02.067
7. Tavares D. C., Barcelos G. R. M., Silva L. F., Tonin C. C. C., Bastos J. K., Propolis-induced genotoxicity and antigenotoxicity in Chinese hamster ovary cells. Toxicology In Vitro 2006 20 7 1154 1158 2-s2.0-33746030029 10.1016/j.tiv.2006.02.009 (Pubitemid 44067378)
8. Murad J. M., Calvi S. A., Soares A. M. V. C., Bankova V., Sforcin J. M., Effects of propolis from Brazil and Bulgaria on fungicidal activity of macrophages against Paracoccidioides brasiliensis. Journal of Ethnopharmacology 2002 79 3 331 334 2-s2.0-0036174770 10.1016/S0378-8741(01)00404-4 (Pubitemid 34155352)
9. Berretta A. A., Nascimento A. P., Bueno P. C., Vaz M. M., Marchetti J. M., Propolis standardized extract (EPP-AF(R)), an innovative chemically and biologically reproducible pharmaceutical compound for treating wounds. International Journal of Biological Sciences 2012 8 4 512 521 10.7150/ijbs.3641
10. de Castro P. A., Savoldi M., Bonatto D., Barros M. H., Goldman M. H. S., Berretta A. A., Goldman G. H., Molecular characterization of propolis-induced cell death in Saccharomyces cerevisiae. Eukaryotic Cell 2011 10 3 398 411 2-s2.0-79952299057 10.1128/EC.00256-10
11. Reis C. M. F., Carvalho J. C. T., Caputo L. K. G., Patri'cio K. C. M., Barbosa M. V. J., Chieff A. L., Bastos J. K., Atividade antiinflamatória, antiúlcera gástrica e toxicidade subcrônica do extrato etanólico de própolis. Revista Brasileira de Farmacognosia 2000 9-10 1 43 52 10.1590/S0102-695X2000000100005
12. Broz P., Monack D. M., Molecular mechanisms of inflammasome activation during microbial infections. Immunological Reviews 2011 243 1 174 190 10.1111/j.1600-065X.2011.01041.x
13. Dunne A., Inflammasome activation: from inflammatory disease to infection. Biochemical Society Transactions 2011 39 2 669 673 2-s2.0-79953203626 10.1042/BST0390669
14. Franchi L., Eigenbrod T., Muñoz-Planillo R., Nuñez G., The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nature Immunology 2009 10 3 241 247 2-s2.0-60749104683 10.1038/ni.1703
15. Lamkanfi M., Kanneganti T. D., Franchi L., Núñez G., Caspase-1 inflammasomes in infection and inflammation. Journal of Leukocyte Biology 2007 82 2 220 225 2-s2.0-34547756483 10.1189/jlb.1206756 (Pubitemid 47230630)
16. Martinon F., Burns K., Tschopp J., The Inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL- β Molecular Cell 2002 10 2 417 426 2-s2.0-0036671894 10.1016/S1097-2765(02)00599-3 (Pubitemid 35007355)
17. Martinon F., Tschopp J., Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death and Differentiation 2007 14 1 10 22 2-s2.0-33845497181 10.1038/sj.cdd.4402038 (Pubitemid 44911890)
18. Miao E. A., Leaf I. A., Treuting P. M., Mao D. P., Dors M., Sarkar A., Warren S. E., Wewers M. D., Aderem A., Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nature Immunology 2010 11 12 1136 1142 2-s2.0-78449269290 10.1038/ni.1960
19. Fink S. L., Cookson B. T., Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cellular Microbiology 2006 8 11 1812 1825 2-s2.0-33749576792 10.1111/j.1462-5822.2006. 00751.x (Pubitemid 44530672)
20. Silveira T. N., Zamboni D. S., Pore formation triggered by Legionella spp. is an Nlrc4 inflammasome-dependent host cell response that precedes pyroptosis. Infection and Immunity 2010 78 3 1403 1413 2-s2.0-77349118460 10.1128/IAI.00905-09
21. Lamkanfi M., Dixit V. M., Inflammasomes: guardians of cytosolic sanctity. Immunological Reviews 2009 227 1 95 105 2-s2.0-58049202273 10.1111/j.1600-065X. 2008.00730.x
22. Newman Z. L., Printz M. P., Liu S., Crown D., Breen L., Miller-Randolph S., Flodman P., Leppla S. H., Moayeri M., Susceptibility to anthrax lethal toxin-induced rat death is controlled by a single chromosome 10 locus that includes rNlrp1. PLoS Pathogens 2010 6 5 1 8 2-s2.0-77954056386 10.1371/journal.ppat.1000906
23. Franchi L., Amer A., Body-Malapel M., Kanneganti T. D., Özören N., Jagirdar R., Inohara N., Vandenabeele P., Bertin J., Coyle A., Grant E. P., Núñez G., Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1 β in salmonella-infected macrophages. Nature Immunology 2006 7 6 576 582 2-s2.0-33744464740 10.1038/ni1346 (Pubitemid 43797338)
24. Ren T., Zamboni D. S., Roy C. R., Dietrich W. F., Vance R. E., Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity. PLoS Pathogens 2006 2 3, article e18 2-s2.0-33744457991 10.1371/journal.ppat.0020018
25. Lightfield K. L., Persson J., Trinidad N. J., Brubaker S. W., Kofoed E. M., Sauer J. D., Dunipace E. A., Warren S. E., Miao E. A., Vance R. E., Differential requirements for NAIP5 in activation of the NLRC4 inflammasome. Infection and Immunity 2011 79 4 1606 1614 2-s2.0-79953315378 10.1128/IAI.01187-10
26. Sutterwala F. S., Ogura Y., Zamboni D. S., Roy C. R., Flavell R. A., NALP3: a key player in caspase-1 activation. Journal of Endotoxin Research 2006 12 4 251 256 2-s2.0-33749047649 10.1179/096805106X118771 (Pubitemid 47470169)
27. Pétrilli V., Papin S., Dostert C., Mayor A., Martinon F., Tschopp J., Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death and Differentiation 2007 14 9 1583 1589 2-s2.0-34548027736 10.1038/sj.cdd.4402195 (Pubitemid 47278844)
28. Wu J., Fernandes-Alnemri T., Alnemri E. S., Involvement of the AIM2, NLRC4, and NLRP3 inflammasomes in caspase-1 activation by Listeria monocytogenes. Journal of Clinical Immunology 2010 30 5 693 702 2-s2.0-77957578665 10.1007/s10875-010-9425-2
29. Bauer C., Duewell P., Mayer C., Lehr H. A., Fitzgerald K. A., Dauer M., Tschopp J., Endres S., Latz E., Schnurr M., Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut 2010 59 9 1192 1199 2-s2.0-77956128040 10.1136/gut.2009.197822
30. Duewell P., Kono H., Rayner K. J., Sirois C. M., Vladimer G., Bauernfeind F. G., Abela G. S., Franchi L., Nuñez G., Schnurr M., Espevik T., Lien E., Fitzgerald K. A., Rock K. L., Moore K. J., Wright S. D., Hornung V., Latz E., NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010 464 7293 1357 1361 10.1038/nature08938
31. Zaki M. H., Boyd K. L., Vogel P., Kastan M. B., Lamkanfi M., Kanneganti T. D., The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 2010 32 3 379 391 2-s2.0-77950002937 10.1016/j.immuni.2010.03.003
32. de Sousa J. P. B., Bueno P. C. P., Gregório L. E., da Silva Filho A. A., Furtado N. A. J. C., de Sousa M. L., Bastos J. K., A reliable quantitative method for the analysis of phenolic compounds in Brazilian propolis by reverse phase high performance liquid chromatography. Journal of Separation Science 2007 30 16 2656 2665 2-s2.0-36448934531 10.1002/jssc.200700228 (Pubitemid 350162200)
33. Berger K. H., Isberg R. R., Two distinct defects in intracellular growth complemented by a single genetic locus in Legionella pneumophila. Molecular Microbiology 1993 7 1 7 19 2-s2.0-0027472133 10.1111/j.1365-2958.1993.tb01092.x (Pubitemid 23011091)
34. Marim F. M., Silveira T. N., Lima D. S. Jr., Zamboni D. S., A method for generation of bone marrow-derived macrophages from cryopreserved mouse bone marrow cells. PloS ONE 2010 5 12 e15263 2-s2.0-79960115330
35. Bazo A. P., Rodrigues M. A. M., Sforcin J. M., de Camargo J. L. V., Ribeiro L. R., Salvadori D. M. F., Protective action of propolis on the rat colon carcinogenesis. Teratogenesis Carcinogenesis and Mutagenesis 2002 22 3 183 194 2-s2.0-0036232790 10.1002/tcm.10011 (Pubitemid 34437646)
36. Chirumbolo S., Propolis as anti-inflammatory and anti-allergic compounds: which role for flavonoids? International Immunopharmacology 2011 11 9 1386 1387 10.1016/j.intimp.2011.03.018
37. Sartori G., Pesarico A. P., Pinton S., Dobrachinski F., Roman S. S., Pauletto F., Junior L. C., Prigol M., Protective effect of brown Brazilian propolis against acute vaginal lesions caused by herpes simplex virus type 2 in mice: involvement of antioxidant and anti-inflammatory mechanisms. Cell Biochemistry and Function 2011 30 1 1 10 10.1002/cbf.1810
38. Contassot E., Beer H. D., French L. E., Interleukin-1, inflammasomes, autoinflammation and the skin. Swiss Medical Weekly 2012 142 w13590 10.4414/smw.2012.13590
39. Banerjee M., Saxena M., Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes. Clinica Chimica Acta 2012 413 15-16 1163 1170 10.1016/j.cca.2012.03.021
40. Gross O., Thomas C. J., Guarda G., Tschopp J., The inflammasome: an integrated view. Immunological Reviews 2011 243 1 136 151 10.1111/j.1600-065X. 2011.01046.x
41. Stout-Delgado H. W., Vaughan S. E., Shirali A. C., Jaramillo R. J., Harrod K. S., Impaired NLRP3 inflammasome function in elderly mice during influenza infection is rescued by treatment with nigericin. Journal of Immunology 2012 188 6 2815 2824 10.4049/jimmunol.1103051
42. Mariathasan S., Weiss D. S., Newton K., McBride J., O'Rourke K., Roose-Girma M., Lee W. P., Weinrauch Y., Monack D. M., Dixit V. M., Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006 440 7081 228 232 2-s2.0-32944470765 10.1038/nature04515 (Pubitemid 43372102)
43. McGahon A. J., Martin S. J., Bissonnette R. P., Mahboubi A., Shi Y., Mogil R. J., Nishioka W. K., Green D. R., Chapter 9 the end of the (cell) line: methods for the study of apoptosis in vitro. Methods in Cell Biology 1995 46 153 185 2-s2.0-0029199452 10.1016/S0091-679X(08)61929-9
44. Zuckman D. M., Hung J. B., Roy C. R., Pore-forming activity is not sufficient for Legionella pneumophila phagosome trafficking and intracellular growth. Molecular Microbiology 1999 32 5 990 1001 2-s2.0-0033019702 10.1046/j.1365-2958.1999.01410.x (Pubitemid 29255765)
45. Smolewski P., Bedner E., Du L., Hsieh T. C., Wu J. M., Phelps D. J., Darzynkiewicz Z., Detection of caspases activation by fluorochrome-labeled inhibitors: multiparameter analysis by laser scanning cytometry. Cytometry 2001 44 1 73 82 10.1002/1097-0320(20010501)44:1<73::AID-CYTO1084>3.0. CO;2-S (Pubitemid 32434005)
46. Zamboni D. S., Kobayashi K. S., Kohlsdorf T., Ogura Y., Long E. M., Vance R. E., Kuida K., Mariathasan S., Dixit V. M., Flavell R. A., Dietrich W. F., Roy C. R., The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nature Immunology 2006 7 3 318 325 2-s2.0-33645770203 10.1038/ni1305
47. Qu Y., Misaghi S., Newton K., Gilmour L. L., Louie S., Cupp J. E., Dubyak G. R., Hackos D., Dixit V. M., Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation. Journal of Immunology 2011 186 11 6553 6561 2-s2.0-79958034097 10.4049/jimmunol.1100478
48. Allam R., Darisipudi M. N., Rupanagudi K. V., Lichtnekert J., Tschopp J., Anders H. J., Cutting edge: cyclic polypeptide and aminoglycoside antibiotics trigger IL-1 β secretion by activating the NLRP3 inflammasome. Journal of Immunology 2011 186 5 2714 2718 2-s2.0-79952747168 10.4049/jimmunol.1002657
49. Miao E. A., Mao D. P., Yudkovsky N., Bonneau R., Lorang C. G., Warren S. E., Leaf I. A., Aderem A., Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proceedings of the National Academy of Sciences of the United States of America 2010 107 7 3076 3080 2-s2.0-77649241461 10.1073/pnas.0913087107
50. Franchi L., Stoolman J., Kanneganti T. D., Verma A., Ramphal R., Núñez G., Critical role for Ipaf in Pseudomonas aeruginosa -induced caspase-1 activation. European Journal of Immunology 2007 37 11 3030 3039 2-s2.0-36248940773 10.1002/eji.200737532 (Pubitemid 350131283)
51. Franchi L., McDonald C., Kanneganti T. D., Amer A., Núñez G., Nucleotide-binding oligomerization domain-like receptors: intracellular pattern recognition molecules for pathogen detection and host defense. Journal of Immunology 2006 177 6 3507 3513 2-s2.0-33748501517 (Pubitemid 44359880)
52. Newman D. J., Cragg G. M., Natural products as sources of new drugs over the last 25 years. Journal of Natural Products 2007 70 3 461 477 2-s2.0-34247109045 10.1021/np068054v (Pubitemid 46595760)
53. Bankova V., Chemical diversity of propolis and the problem of standardization. Journal of Ethnopharmacology 2005 100 1-2 114 117 2-s2.0-23044459404 10.1016/j.jep.2005.05.004 (Pubitemid 41073532)
54. Salatino A., Teixeira E. W., Negri G., Message D., Origin and chemical variation of Brazilian propolis. Evidence-Based Complementary and Alternative Medicine 2005 2 1 33 38 2-s2.0-24344444003 10.1093/ecam/neh060 (Pubitemid 41399512)
55. Ansorge S., Reinhold D., Lendeckel U., Propolis and some of its constituents down-regulate DNA synthesis and inflammatory cytokine production but induce TGF- β 1 production of human immune cells. Zeitschrift fur Naturforschung C 2003 58 7-8 580 589 2-s2.0-0041655892 (Pubitemid 36971463)
56. Korish A. A., Arafa M. M., Propolis derivatives inhibit the systemic inflammatory response and protect hepatic and neuronal cells in acute septic shock. Brazilian Journal of Infectious Diseases 2011 15 4 332 338
57. Song J. J., Cho J. G., Hwang S. J., Cho C. G., Park S. W., Chae S. W., Inhibitory effect of caffeic acid phenethyl ester (CAPE) on LPS-induced inflammation of human middle ear epithelial cells. Acta Oto-Laryngologica 2008 128 12 1303 1307 2-s2.0-57349138897 10.1080/00016480801947082
58. Dinarello C. A., Interleukin-1 β and the autoinflammatory diseases. The New England Journal of Medicine 2009 360 23 2467 2470 2-s2.0-66649122286 10.1056/NEJMe0811014
59. Duncan J. A., Gao X., Huang M. T. H., O'Connor B. P., Thomas C. E., Willingham S. B., Bergstralh D. T., Jarvis G. A., Sparling P. F., Ting J. P. Y., Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. Journal of Immunology 2009 182 10 6460 6469 2-s2.0-70449448992 10.4049/jimmunol.0802696
60. He X., Mekasha S., Mavrogiorgos N., Fitzgerald K. A., Lien E., Ingalls R. R., Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome. Journal of Immunology 2010 184 10 5743 5754 2-s2.0-77954726266 10.4049/jimmunol.0903937
61. Kayagaki N., Warming S., Lamkanfi M., Walle L. V., Louie S., Dong J., Newton K., Qu Y., Liu J., Heldens S., Non-canonical inflammasome activation targets caspase-11. Nature 2011 479 7371 117 121 10.1038/nature10558
62. Toma C., Higa N., Koizumi Y., Nakasone N., Ogura Y., McCoy A. J., Franchi L., Uematsu S., Sagara J., Taniguchi S., Tsutsui H., Akira S., Tschopp J., Núñez G., Suzuki T., Pathogenic Vibrio activate NLRP3 inflammasome via cytotoxins and TLR/nucleotide-binding oligomerization domain-mediated NF- B signaling. Journal of Immunology 2010 184 9 5287 5297 2-s2.0-77954521853 10.4049/jimmunol.0903536
63. Gross O., Poeck H., Bscheider M., Dostert C., Hannesschläger N., Endres S., Hartmann G., Tardivel A., Schweighoffer E., Tybulewicz V., Mocsai A., Tschopp J., Ruland J., Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 2009 459 7245 433 436 2-s2.0-67349271142 10.1038/nature07965
64. Hise A. G., Tomalka J., Ganesan S., Patel K., Hall B. A., Brown G. D., Fitzgerald K. A., An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host and Microbe 2009 5 5 487 497 2-s2.0-65549154784 10.1016/j.chom.2009.05.002
65. Joly S., Ma N., Sadler J. J., Soll D. R., Cassel S. L., Sutterwala F. S., Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. Journal of Immunology 2009 183 6 3578 3581 2-s2.0-70349317039 10.4049/jimmunol.0901323
66. Allen I. C., Scull M. A., Moore C. B., Holl E. K., McElvania-TeKippe E., Taxman D. J., Guthrie E. H., Pickles R. J., Ting J. P. Y., The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009 30 4 556 565 2-s2.0-64049111768 10.1016/j.immuni.2009.02.005
67. Ichinohe T., Pang I. K., Iwasaki A., Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nature Immunology 2010 11 5 404 410 2-s2.0-77951295418 10.1038/ni.1861
68. Rajan J. V., Rodriguez D., Miao E. A., Aderem A., The NLRP3 inflammasome detects encephalomyocarditis virus and vesicular stomatitis virus infection. Journal of Virology 2011 85 9 4167 4172 2-s2.0-79955370281 10.1128/JVI.01687-10
69. Ritter M., Gross O., Kays S., Ruland J., Nimmerjahn F., Saijo S., Tschopp J., Layland L. E., da Costa C. P., Schistosoma mansoni triggers Dectin-2, which activates the Nlrp3 inflammasome and alters adaptive immune responses. Proceedings of the National Academy of Sciences of the United States of America 2010 107 47 20459 20464 2-s2.0-78650544477 10.1073/pnas.1010337107
70. Halle A., Hornung V., Petzold G. C., Stewart C. R., Monks B. G., Reinheckel T., Fitzgerald K. A., Latz E., Moore K. J., Golenbock D. T., The NALP3 inflammasome is involved in the innate immune response to amyloid- β Nature Immunology 2008 9 8 857 865 2-s2.0-47849085872 10.1038/ni.1636
71. Martinon F., Pétrilli V., Mayor A., Tardivel A., Tschopp J., Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006 440 7081 237 241 2-s2.0-32944468985 10.1038/nature04516 (Pubitemid 43372104)
72. Shinkai K., McCalmont T. H., Leslie K. S., Cryopyrin-associated periodic syndromes and autoinflammation. Clinical and Experimental Dermatology 2008 33 1 1 9 2-s2.0-37349036932 10.1111/j.1365-2230.2007.02540.x (Pubitemid 350308516)